Ligand validation:3V2J

AZM: 5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE

AZM is a Ligand Of Interest in 3V2J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V2J_AZM_A_302	99%	0%	0.057	0.994	3.03	6.43	5	6	0	0	100%	1
3DC3_AZM_A_263	99%	1%	0.055	0.991	6.01	2.36	4	5	0	0	100%	1
3HS4_AZM_A_701	97%	10%	0.077	0.991	1.48	2.74	1	3	0	0	100%	1
6YMA_AZM_A_302	87%	30%	0.104	0.977	1.93	0.87	2	1	0	0	100%	1
4K0S_AZM_A_302	87%	7%	0.088	0.96	2.44	2.4	4	5	2	0	100%	1
3V2M_AZM_A_303	41%	3%	0.179	0.893	2.93	3.3	6	6	4	0	100%	0.8
4G7A_AZM_B_302	100%	27%	0.04	0.99	1.12	1.8	-	2	0	0	100%	1
4LU3_AZM_A_302	100%	17%	0.049	0.991	0.81	2.76	-	2	0	0	100%	1
7COJ_AZM_B_302	98%	27%	0.067	0.99	0.65	2.25	-	2	2	0	100%	1
4UOV_AZM_C_299	97%	31%	0.076	0.991	0.28	2.41	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.